000 01561 a2200433 4500
005 20250518101101.0
264 0 _c20210623
008 202106s 0 0 eng d
022 _a1740-634X
024 7 _a10.1038/s41386-020-0685-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aXia, Luyao
245 0 0 _aOne-day tropisetron treatment improves cognitive deficits and P50 inhibition deficits in schizophrenia.
_h[electronic resource]
260 _bNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
_c07 2020
300 _a1362-1368 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aCognition
650 0 4 _aCognition Disorders
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aSchizophrenia
_xdrug therapy
650 0 4 _aSensory Gating
650 0 4 _aTropisetron
700 1 _aLiu, Lei
700 1 _aHong, Xiaohong
700 1 _aWang, Dongmei
700 1 _aWei, Gaoxia
700 1 _aWang, Jiesi
700 1 _aZhou, Huixia
700 1 _aXu, Hang
700 1 _aTian, Yang
700 1 _aDai, Qilong
700 1 _aWu, Hanjing E
700 1 _aChang, Catherine
700 1 _aWang, Li
700 1 _aKosten, Thomas R
700 1 _aZhang, Xiang Yang
773 0 _tNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
_gvol. 45
_gno. 8
_gp. 1362-1368
856 4 0 _uhttps://doi.org/10.1038/s41386-020-0685-0
_zAvailable from publisher's website
999 _c30914927
_d30914927